Cargando...
Recent progress in the strategic incorporation of fluorine into medicinally active compounds
This account exemplifies our recent progress on the strategic incorporation of fluorine and organofluorine groups to (i) taxoid anticancer agents, (ii) acylhydrazone-based antifungal agents and (iii) inhibitors of matrix metalloproteinase 9 (MMP9) for medicinal chemistry and chemical biology studies...
Guardado en:
| Publicado en: | J Fluor Chem |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6752223/ https://ncbi.nlm.nih.gov/pubmed/31537946 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jfluchem.2018.11.002 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|